Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Ticagrelor versus clopidogrel in patients undergoing implantation of paclitaxel-eluting stent in the femoropopliteal district: A randomized pilot study using frequency-domain optical coherence tomography.

Ducci K, Liistro F, Porto I, Ventoruzzo G, Angioli P, Falsini G, Vergallo R, Bolognese L.

Int J Cardiol. 2020 Apr 1;304:192-197. doi: 10.1016/j.ijcard.2020.01.024. Epub 2020 Jan 15.

PMID:
32007230
2.

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial.

Takahashi K, Kogame N, Tomaniak M, Chichareon P, Chang CC, Modolo R, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Buszman P, Bolognese L, Tumscitz C, Żmudka K, Aminian A, Vrolix M, Petrov I, Wykrzykowska JJ, de Winter RJ, Hamm C, Steg PG, Onuma Y, Valgimigli M, Windecker S, Vranckx P, Garg S, Serruys PW.

Clin Res Cardiol. 2019 Dec 11. doi: 10.1007/s00392-019-01585-w. [Epub ahead of print]

PMID:
31828504
3.

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.

Tavenier AH, Hermanides RS, Fabris E, Lapostolle F, Silvain J, Ten Berg JM, Lassen JF, Bolognese L, Cantor WJ, Cequier Á, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Ecollan P, Collet JP, Willems FF, Diallo A, Vicaut E, Hamm CW, Montalescot G, van 't Hof AWJ; ATLANTIC investigators.

Thromb Haemost. 2020 Jan;120(1):65-74. doi: 10.1055/s-0039-1700546. Epub 2019 Nov 21.

PMID:
31752042
4.

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.

Franzone A, McFadden E, Leonardi S, Piccolo R, Vranckx P, Serruys PW, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, Diletti R, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg PG, Heg D, Jüni P, Windecker S, Valgimigli M; GLASSY Investigators.

J Am Coll Cardiol. 2019 Nov 5;74(18):2223-2234. doi: 10.1016/j.jacc.2019.08.1038.

PMID:
31672177
5.

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.

Serruys PW, Takahashi K, Chichareon P, Kogame N, Tomaniak M, Modolo R, Chang CC, Komiyama H, Soliman O, Wykrzykowska JJ, de Winter RJ, Ferrario M, Dominici M, Buszman P, Bolognese L, Tumscitz C, Benit E, Stoll HP, Hamm C, Steg PG, Onuma Y, Jüni P, Windecker S, Vranckx P, Colombo A, Valgimigli M.

Eur Heart J. 2019 Aug 14;40(31):2595-2604. doi: 10.1093/eurheartj/ehz453.

PMID:
31397487
6.

Myocardial ischemia and coronary disease in heart failure.

Pagliaro BR, Cannata F, Stefanini GG, Bolognese L.

Heart Fail Rev. 2020 Jan;25(1):53-65. doi: 10.1007/s10741-019-09831-z. Review.

PMID:
31332663
7.

Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study.

Liistro F, Angioli P, Porto I, Ducci K, Falsini G, Ventoruzzo G, Ricci L, Scatena A, Grotti S, Bolognese L.

J Am Coll Cardiol. 2019 Jul 16;74(2):205-215. doi: 10.1016/j.jacc.2019.04.057.

PMID:
31296293
8.

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial.

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang CC, Tomaniak M, Asano T, Katagiri Y, van Geuns RM, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber CK, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek JJ, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys PW.

EuroIntervention. 2019 Aug 9;15(6):e539-e546. doi: 10.4244/EIJ-D-19-00184.

9.

Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study.

Bauer T, Zeymer U, Diallo A, Vicaut E, Bolognese L, Cequier A, Huber K, Montalescot G, Hamm CW, Van't Hof AW; ATLANTIC Investigators.

Catheter Cardiovasc Interv. 2020 Feb 15;95(3):494-500. doi: 10.1002/ccd.28318. Epub 2019 May 8.

PMID:
31067010
10.

[The dawn era in the management of acute ischemic stroke and its health policy implications. Should interventional cardiologists be involved?]

Falsini G, Calchetti B, Liistro F, Linoli G, Picchi A, Angioli P, Ducci K, Limbruno U, Marconi R, Bolognese L.

G Ital Cardiol (Rome). 2019 May;20(5):258-264. doi: 10.1714/3151.31318. Italian.

PMID:
31066368
11.

[The GLOBAL LEADERS trial: do we still need aspirin in acute coronary syndrome patients undergoing percutaneous coronary intervention?]

Bolognese L.

G Ital Cardiol (Rome). 2019 May;20(5):255-257. doi: 10.1714/3151.31317. Italian. No abstract available.

PMID:
31066367
12.

Brugada Syndrome in the Young and in the Adult: A Tale of 2 Diseases?

Pieroni M, Notarstefano P, Bolognese L.

J Am Coll Cardiol. 2019 Apr 16;73(14):1766-1768. doi: 10.1016/j.jacc.2019.01.047. No abstract available.

PMID:
30975292
13.

Moderate aortic stenosis and left ventricular dysfunction: an ominous association.

Sabini A, Bolognese L.

Eur Heart J Suppl. 2019 Mar;21(Suppl B):B15-B16. doi: 10.1093/eurheartj/suz012. Epub 2019 Mar 29. No abstract available.

14.

Reply: Myocardial Inflammation in Brugada Syndrome.

Pieroni M, Notarstefano P, Oliva A, Santangeli P, Bolognese L.

J Am Coll Cardiol. 2019 Mar 26;73(11):1370. doi: 10.1016/j.jacc.2019.01.023. No abstract available. Erratum in: J Am Coll Cardiol. 2019 Apr 23;73(15):2010.

15.

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Leonardi S, Franzone A, Piccolo R, McFadden E, Vranckx P, Serruys P, Benit E, Liebetrau C, Janssens L, Ferrario M, Zurakowski A, van Geuns RJ, Dominici M, Huber K, Slagboom T, Buszman P, Bolognese L, Tumscitz C, Bryniarski K, Aminian A, Vrolix M, Petrov I, Garg S, Naber C, Prokopczuk J, Hamm C, Steg G, Heg D, Juni P, Windecker S, Valgimigli M.

BMJ Open. 2019 Mar 9;9(3):e026053. doi: 10.1136/bmjopen-2018-026053.

16.

Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction.

Silvain J, Rakowski T, Lattuca B, Liu Z, Bolognese L, Goldstein P, Hamm C, Tanguay JF, Ten Berg J, Widimsky P, Miller D, Portal JJ, Collet JP, Vicaut E, Montalescot G, Dudek D; ACCOAST Investigators.

J Am Coll Cardiol. 2019 Mar 5;73(8):906-914. doi: 10.1016/j.jacc.2018.11.055.

17.

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel.

Crimi G, Morici N, Ferrario M, Ferri LA, Piatti L, Grosseto D, Cacucci M, Mandurino Mirizzi A, Toso A, Piscione F, De Carlo M, Elia LR, Trimarco B, Bolognese L, Bovenzi FM, De Luca G, Savonitto S, De Servi S.

J Am Heart Assoc. 2019 Jan 22;8(2):e010956. doi: 10.1161/JAHA.118.010956.

18.

Electroanatomic and Pathologic Right Ventricular Outflow Tract Abnormalities in Patients With Brugada Syndrome.

Pieroni M, Notarstefano P, Oliva A, Campuzano O, Santangeli P, Coll M, Nesti M, Carnevali A, Fraticelli A, Iglesias A, Grassi S, Brugada R, Bolognese L.

J Am Coll Cardiol. 2018 Dec 4;72(22):2747-2757. doi: 10.1016/j.jacc.2018.09.037.

19.

Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine.

Lapostolle F, Van't Hof AW, Hamm CW, Stibbe O, Ecollan P, Collet JP, Silvain J, Lassen JF, Heutz WMJM, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Ten Berg J, Zeymer U, Licour M, Tsatsaris A, Montalescot G; ATLANTIC Investigators.

Am J Cardiovasc Drugs. 2019 Apr;19(2):173-183. doi: 10.1007/s40256-018-0305-0.

PMID:
30353444
20.

Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.

Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Kerneis M, Diallo A, Vicaut E, Montalescot G; ATLANTIC investigators.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E369-E377. doi: 10.1002/ccd.27921. Epub 2018 Oct 9.

PMID:
30302940
21.

Trends in management and outcome of patients with non-ST elevation acute coronary syndromes and peripheral arterial disease.

De Luca L, Di Pasquale G, Gonzini L, Chiarella F, Di Chiara A, Boccanelli A, Casella G, Olivari Z, De Servi S, Gulizia MM, Di Lenarda A, Savonitto S, Bolognese L.

Eur J Intern Med. 2019 Jan;59:70-76. doi: 10.1016/j.ejim.2018.08.010. Epub 2018 Aug 25.

PMID:
30154039
22.

[Dual antiplatelet therapy in elderly patients with acute coronary syndrome: does age make the difference?]

Tarantini G, Cirillo P, De Servi S, Parodi G, Capodanno D, D'Amico G, Boccanelli A, Cattaneo M, Bolognese L, Cavallini C, Musumeci G, Marchionni N.

G Ital Cardiol (Rome). 2018 Jul-Aug;19(7):420-428. doi: 10.1714/2938.29538. Italian.

PMID:
29989599
23.

P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use.

Grotti S, Bolognese L.

J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e9-e12. doi: 10.2459/JCM.0000000000000595. Review. No abstract available.

PMID:
29538137
24.

[Temporal evolution of antithrombotic therapy use in patients with acute coronary syndromes undergoing percutaneous coronary intervention in Italy: comparison between the EYESHOT and SCOPE registries].

De Luca L, Pennacchi M, Musumeci G, D'Ascenzo F, Gallo P, Rigattieri S, Granatelli A, Berti S, Gulizia MM, De Servi S, Bolognese L; a nome dei Ricercatori EYESHOT e SCOPE.

G Ital Cardiol (Rome). 2018 Feb;19(2):101-110. doi: 10.1714/2868.28941. Italian.

PMID:
29531382
25.

Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study.

Bagai A, Goodman SG, Cantor WJ, Vicaut E, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Merkely B, Storey RF, Ten Berg JM, Zeymer U, Diallo A, Hamm CW, Tsatsaris A, El Khoury J, Van't Hof AW, Montalescot G.

Am Heart J. 2018 Feb;196:56-64. doi: 10.1016/j.ahj.2017.10.021. Epub 2017 Nov 4.

PMID:
29421015
26.

Is ticagrelor safe in octogenarian patients with non-ST elevation acute coronary syndromes?

De Luca L, De Servi S, Musumeci G, Bolognese L.

Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):12-14. doi: 10.1093/ehjcvp/pvx034. No abstract available.

PMID:
29088411
27.

Long-term prognostic value of delirium in elderly patients with acute cardiac diseases admitted to two cardiac intensive care units: a prospective study (DELIRIUM CORDIS).

Falsini G, Grotti S, Porto I, Toccafondi G, Fraticelli A, Angioli P, Ducci K, Liistro F, Pieroni M, Taddei T, Romanelli S, Rossi R, Bolognese L.

Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):661-670. doi: 10.1177/2048872617695235. Epub 2017 Mar 16.

PMID:
29064263
28.

Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial.

Fabris E, van 't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Tsatsaris A, Kerneis M, Diallo A, Vicaut E, Montalescot G.

Eur Heart J Acute Cardiovasc Care. 2019 Apr;8(3):208-217. doi: 10.1177/2048872617727722. Epub 2017 Aug 25.

PMID:
28841028
29.

ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

Gulizia MM, Colivicchi F, Ricciardi G, Giampaoli S, Maggioni AP, Averna M, Graziani MS, Ceriotti F, Mugelli A, Rossi F, Medea G, Parretti D, Abrignani MG, Arca M, Perrone Filardi P, Perticone F, Catapano A, Griffo R, Nardi F, Riccio C, Di Lenarda A, Scherillo M, Musacchio N, Panno AV, Zito GB, Campanini M, Bolognese L, Faggiano PM, Musumeci G, Pusineri E, Ciaccio M, Bonora E, Cantelli Forti G, Ruggieri MP, Cricelli C, Romeo F, Ferrari R, Maseri A.

Eur Heart J Suppl. 2017 May;19(Suppl D):D3-D54. doi: 10.1093/eurheartj/sux029. Epub 2017 May 2.

30.

All-cause and cardiovascular mortality in a consecutive series of patients with diabetic foot osteomyelitis.

Ricci L, Scatena A, Tacconi D, Ventoruzzo G, Liistro F, Bolognese L, Monami M, Mannucci E.

Diabetes Res Clin Pract. 2017 Sep;131:12-17. doi: 10.1016/j.diabres.2017.06.006. Epub 2017 Jun 15.

PMID:
28668718
31.

Incidence and outcome of switching of oral platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: the SCOPE registry.

De Luca L, D'Ascenzo F, Musumeci G, Saia F, Parodi G, Varbella F, Marchese A, De Servi S, Berti S, Bolognese L.

EuroIntervention. 2017 Jul 20;13(4):459-466. doi: 10.4244/EIJ-D-17-00092.

32.

The 2016 Year in Cardiology Series of the European Heart Journal.

Bolognese L.

Eur Heart J. 2017 Jan 14;38(3):130. doi: 10.1093/eurheartj/ehw615. No abstract available.

PMID:
28158666
33.

Italian contributions to cardiovascular research during the last 20 years.

Bolognese L.

Eur Heart J. 2017 Jan 14;38(3):130-135. doi: 10.1093/eurheartj/ehw616. No abstract available.

PMID:
28158520
34.

The Italian Federation of Cardiology.

Bolognese L.

Eur Heart J. 2017 Jan 14;38(3):135-136. doi: 10.1093/eurheartj/ehw617. No abstract available.

PMID:
28158499
35.

Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial.

Fabris E, Van't Hof A, Hamm CW, Lapostolle F, Lassen JF, Goodman SG, Ten Berg JM, Bolognese L, Cequier A, Chettibi M, Hammett CH, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Cantor WJ, Rousseau H, Vicaut E, Montalescot G.

EuroIntervention. 2017 May 15;13(1):69-77. doi: 10.4244/EIJ-D-16-00965.

PMID:
28134127
36.

Electrical treatment of atrial arrhythmias in heart failure patients implanted with a dual defibrillator CRT device. Results from the TRADE-HF study.

Botto GL, Padeletti L, Covino G, Pieragnoli P, Liccardo M, Mariconti B, Favale S, Molon G, De Filippo P, Bolognese L, Landolina M, Raciti G, Boriani G.

Int J Cardiol. 2017 Jun 1;236:181-186. doi: 10.1016/j.ijcard.2017.01.101. Epub 2017 Jan 19.

PMID:
28131706
37.

Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.

Zeng Y, Cavalcante R, Tenekecioglu E, Suwannasom P, Sotomi Y, Collet C, Abdelghani M, Jonker H, Digne F, Horstkotte D, Zehender M, Indolfi C, Saia F, Fiorilli R, Chevalier B, Bolognese L, Goicolea J, Nie S, Onuma Y, Serruys PW; investigators of Absorb II study.

Int J Cardiovasc Imaging. 2017 Apr;33(4):441-449. doi: 10.1007/s10554-016-1033-7. Epub 2016 Dec 23.

38.

[The five most important novelties in the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

De Luca L, Bolognese L.

G Ital Cardiol (Rome). 2016 Oct;17(10):802-805. doi: 10.1714/2464.25796. Italian. No abstract available.

PMID:
27869897
39.

Interventional cardiology is changing: demographic, clinical and economic considerations.

Grotti S, Bolognese L.

J Cardiovasc Med (Hagerstown). 2017 Jan;18 Suppl 1:e67-e70. doi: 10.2459/JCM.0000000000000451. No abstract available.

PMID:
27828826
40.

Drug-Coated Balloon in Complex Clinical and Anatomical Scenario: Evidence or Hope?

Liistro F, Bolognese L.

JACC Cardiovasc Interv. 2016 Sep 26;9(18):1950-2. doi: 10.1016/j.jcin.2016.07.039. No abstract available.

41.

Radial access in patients with acute coronary syndrome without persistent ST-segment elevation: Systematic review, collaborative meta-analysis, and meta-regression.

Andò G, Porto I, Montalescot G, Bolognese L, Trani C, Oreto G, Harrington RA, Bhatt DL.

Int J Cardiol. 2016 Nov 1;222:1031-1039. doi: 10.1016/j.ijcard.2016.07.228. Epub 2016 Jul 30. Review.

PMID:
27537543
42.

[ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Consensus document. Hypercholesterolemia and cardiovascular risk: diagnostic and therapeutic pathways in Italy].

Gulizia MM, Colivicchi F, Ricciardi G, Giampaoli S, Maggioni AP, Averna M, Graziani MS, Ceriotti F, Mugelli A, Rossi F, Medea G, Parretti D, Abrignani MG, Arca M, Filardi PP, Perticone F, Catapano A, Griffo R, Nardi F, Riccio C, Di Lenarda A, Scherillo M, Musacchio N, Panno AV, Zito GB, Campanini M, Bolognese L, Faggiano PM, Musumeci G, Pusineri E, Ciaccio M, Bonora E, Cantelli Forti G, Ruggieri MP, Cricelli C, Romeo F, Ferrari R, Maseri A.

G Ital Cardiol (Rome). 2016 Jun;17(6 Suppl 1):3S-57. doi: 10.1714/2264.24358. Italian.

PMID:
27312138
43.

Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.

Porto I, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, Ten Berg J, Widimský P, Le Gall N, Zagar AJ, LeNarz LA, Miller D, Montalescot G; ACCOAST Investigators.

JACC Cardiovasc Interv. 2016 May 9;9(9):897-907. doi: 10.1016/j.jcin.2016.01.041.

44.

Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.

Montalescot G, van 't Hof AW, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Collet JP, Goodman SG, Hammett CJ, Huber K, Janzon M, Lapostolle F, Lassen JF, Licour M, Merkely B, Salhi N, Silvain J, Storey RF, Ten Berg JM, Tsatsaris A, Zeymer U, Vicaut E, Hamm CW; ATLANTIC Investigators.

JACC Cardiovasc Interv. 2016 Apr 11;9(7):646-56. doi: 10.1016/j.jcin.2015.12.024. Epub 2016 Mar 5.

45.

[A rare cause of dyspnea on exertion].

Maccari U, Rosini CF, Scala R, Magnolfi AL, Felici M, Bolognese L.

G Ital Cardiol (Rome). 2016 Jan;17(1):58-61. doi: 10.1714/2140.23194. Italian.

PMID:
26901260
46.

Takotsubo (Stress) Cardiomyopathy.

Pieroni M, Bolognese L.

N Engl J Med. 2015 Dec 31;373(27):2689. doi: 10.1056/NEJMc1512595. No abstract available.

PMID:
26716928
47.

[In memoriam of Antonio Montinaro].

Colonna G, Bolognese L.

G Ital Cardiol (Rome). 2015 Dec;16(12):741. doi: 10.1714/2088.22596. Italian. No abstract available.

PMID:
26667951
48.

Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study.

Dudek D, Dziewierz A, Widimsky P, Bolognese L, Goldstein P, Hamm C, Tanguay JF, LeNarz L, Miller DL, Brown E, Ten Berg J, Montalescot G; ACCOAST Investigators.

Am Heart J. 2015 Nov;170(5):1025-1032.e2. doi: 10.1016/j.ahj.2015.07.017. Epub 2015 Jul 26.

PMID:
26542513
49.

Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.

Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.

J Endovasc Ther. 2016 Feb;23(1):52-7. doi: 10.1177/1526602815614555. Epub 2015 Oct 28.

PMID:
26511896
50.

Antithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction.

Savonitto S, De Luca G, Goldstein P, van T' Hof A, Zeymer U, Morici N, Thiele H, Montalescot G, Bolognese L.

Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):173-190. doi: 10.1177/2048872615590148. Epub 2016 Sep 22. Review.

PMID:
26124456

Supplemental Content

Loading ...
Support Center